Key facts
- Blue Owl Capital is planning to raise $750 million.
- The funds are intended to pay down Blue Owl Capital's credit lines.
- Blue Owl Capital recently provided a $750 million term loan to TG Therapeutics.
Blue Owl Capital is reportedly preparing to raise $750 million with the intention of paying down its existing credit facilities. The firm has been a significant player in the credit market, frequently providing financing solutions to other businesses. One such recent transaction involved Blue Owl extending a $750 million term loan to TG Therapeutics. This action underscores Blue Owl's dual role as both a borrower and a lender within the financial ecosystem. The specific details regarding the planned fundraising for the credit line paydown have not yet been disclosed, but the intention signals a strategic move to manage its own leverage or financial obligations.